Men who consistently avoid prostate cancer screening appointments have a disproportionately higher risk of dying from the disease. This is shown by a study that has also identified a new high-risk group.
Autoren
- Birke Dikken
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Immunotherapy
Subcutaneously or intravenously?
- Cannabis - medical vs. non-medical use
Interim assessment: the boundaries are fluid
- Case Report
Cutaneous myiasis caused by botfly larvae
- Chronic insomnia, REM sleep instability and emotional dysregulation
Risk factors for anxiety and depression
- Immune sensors
Dysfunctional signaling pathways in cardiomyocytes and their role in heart disease
- Inoperable NSCLC
Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy
- Dementia
Recognize incipient progression and identify countermeasures
- Subtype-specific risks and implications for neurological care